ATG39 Antibody

What is ATG39 and why is it significant in autophagy research?

ATG39 is a nuclear envelope (NE) protein in Saccharomyces cerevisiae that functions as a nucleophagy receptor. It is particularly significant because it plays critical roles in both linking and deforming the outer nuclear membrane (ONM) and inner nuclear membrane (INM). ATG39 facilitates the formation of nucleus-derived double-membrane vesicles (NDVs) that are eventually degraded by autophagy. The protein contains a transmembrane domain that anchors it to the ONM, with its N-terminal region exposed to the cytoplasm and C-terminal region to the perinuclear space. This topology allows it to interact with key autophagy machinery components like Atg8 and Atg11 via its cytoplasmic domain while simultaneously binding to the INM through amphipathic helices (APHs) in its perinuclear space region . Understanding ATG39 provides crucial insights into the selective degradation of nuclear components, a process implicated in maintaining nuclear homeostasis.

How does ATG39 topology inform antibody selection for different experimental applications?

When selecting ATG39 antibodies, researchers must consider the protein's membrane topology. ATG39 is a single-pass membrane protein with its N-terminal domain (residues 1-144) exposed to the cytoplasm and its C-terminal domain (residues 165-398) extending into the perinuclear space . For immunofluorescence or flow cytometry experiments on intact cells, antibodies targeting the N-terminal domain are preferable since this region is accessible without membrane permeabilization. Conversely, for detecting ATG39 in fixed and permeabilized samples, antibodies against either domain can be used. For immunoprecipitation experiments, N-terminal-targeting antibodies are generally more effective as they can capture the protein in its native conformation within membrane fractions. Western blotting applications may benefit from antibodies targeting either domain, though N-terminal antibodies often provide clearer results due to the functional importance of this region in Atg8 and Atg11 binding .

What are the key structural domains of ATG39 that researchers should consider when using domain-specific antibodies?

ATG39 contains several critical structural domains that researchers should consider when designing experiments with domain-specific antibodies. The N-terminal cytoplasmic domain (residues 1-144) contains the Atg8-interacting motif (AIM) and the Atg11-binding region (11BR), which are essential for autophagosome recruitment and formation . The single transmembrane domain (approximately residues 145-164) anchors the protein to the ONM. The C-terminal domain in the perinuclear space contains two crucial amphipathic helices (APHs): APH297-324 and another in the 325-398 region . These APHs mediate binding to the INM and are vital for ATG39 retention in the NE, assembly, and NE protrusion formation. Domain-specific antibodies can be valuable tools for dissecting the function of each region, particularly when studying mutants with deletions or modifications to specific domains. For example, antibodies specific to the APH regions can help assess how mutations affect INM binding capacity .

What are the optimal methods for detecting ATG39 localization during nucleophagy?

The optimal detection of ATG39 localization during nucleophagy requires a combination of techniques. Immunofluorescence microscopy using specific anti-ATG39 antibodies is effective when coupled with nuclear envelope markers (like Nup49 for nuclear pore complexes) and autophagy markers (such as Atg8). For live-cell imaging, expressing fluorescently tagged ATG39 (e.g., ATG39-GFP or ATG39-mCherry) allows for tracking protein dynamics during nucleophagy induction. Confocal microscopy with Z-stack acquisition is recommended for accurately visualizing the nuclear envelope protrusions (200-300 nm in diameter) that form during nucleophagy . Super-resolution microscopy techniques such as structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) provide enhanced resolution for detailed examination of ATG39 assembly and distribution at sites of NDV formation. For quantitative analysis, automated image processing algorithms can track the formation of bright ATG39 puncta, which colocalize with Atg8 upon rapamycin treatment or nitrogen starvation . Electron microscopy with immunogold labeling using ATG39 antibodies provides ultrastructural details of NDV formation at nanometer resolution.

How should researchers validate ATG39 antibody specificity for autophagy studies?

Validating ATG39 antibody specificity for autophagy studies requires a multi-step approach. First, researchers should perform western blot analysis comparing wild-type and atg39Δ mutant strains to confirm antibody specificity—a specific antibody will show a band at the expected molecular weight (~45 kDa) in wild-type samples that is absent in the knockout . Second, peptide competition assays should be conducted, where pre-incubation of the antibody with the immunizing peptide should eliminate signal in immunoblotting and immunofluorescence. Third, immunoprecipitation followed by mass spectrometry can verify that the antibody captures the intended protein. For immunofluorescence validation, colocalization studies using cells expressing tagged ATG39 (e.g., ATG39-GFP) should show overlapping signals with the antibody staining. Additionally, testing the antibody's reactivity in autophagy-inducing conditions (rapamycin treatment or nitrogen starvation) versus normal conditions should show characteristic changes in ATG39 localization and abundance . Finally, cross-reactivity assessment with related proteins, particularly other autophagy receptors, is crucial to ensure signal specificity in complex experimental setups.

What are the recommended protocols for using ATG39 antibodies in co-immunoprecipitation studies?

For effective co-immunoprecipitation (co-IP) studies using ATG39 antibodies, researchers should follow a specialized protocol that accounts for ATG39's membrane localization. Begin by harvesting yeast cells during active nucleophagy (typically 3-6 hours after rapamycin treatment or nitrogen starvation) . Prepare cell lysates using a membrane-protein-compatible lysis buffer containing 1% digitonin or 0.5% NP-40, which maintains protein-protein interactions while solubilizing membrane proteins. Include protease inhibitors and phosphatase inhibitors to prevent degradation and maintain post-translational modifications. Pre-clear lysates with protein A/G beads to reduce non-specific binding. For the IP, use 2-5 μg of ATG39 antibody per 1 mg of total protein and incubate overnight at 4°C with gentle rotation. When investigating ATG39 interactions with autophagy machinery components like Atg8 or Atg11, use cross-linking agents such as DSP (dithiobis(succinimidyl propionate)) before lysis to stabilize transient interactions . For washing, use buffers with decreasing detergent concentrations to preserve specific interactions while removing non-specific binding. Elute immune complexes by boiling in SDS sample buffer or using specific peptide elution for gentler extraction. Analyze by western blotting, probing for known interaction partners like Atg8 and Atg11 as positive controls .

How can ATG39 antibodies be used to study the membrane deformation mechanism during nucleophagy?

ATG39 antibodies can be powerful tools for investigating membrane deformation during nucleophagy through several advanced approaches. Immunoelectron microscopy using gold-conjugated ATG39 antibodies allows visualization of protein distribution at sites of nuclear envelope protrusion, providing insights into how ATG39 concentrates at deformation sites . For studying the dynamics of membrane deformation, researchers can combine ATG39 immunostaining with super-resolution microscopy techniques like STED or PALM, focusing on cells expressing fluorescently tagged membrane markers. Time-lapse imaging coupled with quantitative image analysis can track the progression of ATG39 assembly and corresponding membrane curvature changes . To investigate the role of ATG39's amphipathic helices (APHs) in membrane deformation, researchers can compare wild-type ATG39 with mutants lacking these helices (e.g., ATG39 1-296) using domain-specific antibodies. This approach reveals how APH deletion significantly reduces nuclear envelope tubulation, confirming their critical role in membrane deformation . Additionally, proximity labeling techniques using BioID or APEX2 fused to ATG39, followed by pull-down with ATG39 antibodies, can identify proteins that associate with ATG39 specifically during membrane deformation events, potentially uncovering additional factors involved in this process.

What techniques can be used with ATG39 antibodies to investigate the protein's conformational changes during nucleophagy?

To investigate ATG39 conformational changes during nucleophagy, researchers can employ several sophisticated techniques in conjunction with domain-specific antibodies. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) combined with immunoprecipitation using ATG39 antibodies can map regions of the protein that undergo structural rearrangements during nucleophagy induction. Förster resonance energy transfer (FRET) analysis using antibody fragments conjugated with appropriate fluorophores can detect nanometer-scale changes in protein conformation in living cells . Limited proteolysis experiments, where ATG39 is partially digested with proteases in different nucleophagy states before antibody detection, can identify regions that become more accessible or protected during activation. For studying ATG39 oligomerization during assembly at the nuclear envelope, researchers can use size exclusion chromatography multiangle light scattering (SEC-MALS) after immunoprecipitation with ATG39 antibodies . Single-molecule fluorescence techniques with labeled antibody fragments provide insights into the dynamics of conformational changes at the individual protein level. Finally, cross-linking mass spectrometry (XL-MS) after ATG39 immunoprecipitation can map interaction surfaces and conformational states by identifying amino acids in close proximity during different stages of nucleophagy.

How can researchers use ATG39 antibodies to differentiate between basal and induced nucleophagy in yeast models?

Differentiating between basal and induced nucleophagy using ATG39 antibodies requires methodological approaches that can detect changes in ATG39 distribution, abundance, and interactions. Quantitative immunoblotting comparing ATG39 levels before and after nucleophagy induction (via rapamycin treatment or nitrogen starvation) reveals increased protein expression during induced nucleophagy . Immunofluorescence microscopy using ATG39 antibodies shows a distinctive pattern change from diffuse nuclear envelope localization in basal conditions to concentrated puncta during induced nucleophagy . For quantitative assessment, researchers can measure the number and intensity of ATG39-positive puncta, as studies have demonstrated that rapamycin treatment increases both parameters significantly compared to basal conditions. Co-immunoprecipitation experiments using ATG39 antibodies followed by detection of interaction partners reveal stronger associations with Atg8 and Atg11 during induced nucleophagy . Proximity ligation assays (PLA) combining ATG39 antibodies with antibodies against autophagy markers provide in situ visualization of protein interactions that increase during induction. Flow cytometry analysis of immunostained yeast can quantify population-level changes in ATG39 signal intensity and colocalization with other markers. The following table summarizes key differences that can be observed:

How should researchers address cross-reactivity concerns when using ATG39 antibodies in different yeast species or potential mammalian homologs?

Addressing cross-reactivity concerns when using ATG39 antibodies across species requires systematic validation approaches. For cross-species applications within yeasts, researchers should first perform sequence alignment analysis of ATG39 across target species to identify conserved and divergent epitopes. Antibodies targeting highly conserved regions (such as the AIM or transmembrane domain) offer better cross-reactivity potential than those targeting variable regions . When testing antibodies in non-S. cerevisiae yeasts, validation should include western blotting with both positive controls (S. cerevisiae lysates) and the species of interest, confirming appropriate molecular weight bands and their absence in knockout strains. For potential mammalian homologs, the situation is more complex as clear ATG39 orthologs have not been definitively identified. Initial screening should include immunoprecipitation followed by mass spectrometry to identify captured proteins, with subsequent bioinformatic analysis to assess functional domain conservation . When testing functional conservation, researchers should examine whether the captured mammalian proteins localize to the nuclear envelope and interact with mammalian ATG8 homologs (LC3/GABARAP family proteins). To minimize non-specific binding, use higher antibody dilutions (1:1000 instead of 1:500 for western blotting) and more stringent washing conditions. Development of monoclonal antibodies targeting specific conserved epitopes can significantly reduce cross-reactivity issues compared to polyclonal alternatives. Validation should always include appropriate negative controls such as pre-immune serum and isotype-matched control antibodies .

What strategies can researchers employ to optimize ATG39 antibody performance in samples with low expression levels?

Optimizing ATG39 antibody performance for detecting low abundance protein requires multiple technical strategies. For western blotting applications, researchers should begin by enriching the nuclear fraction through subcellular fractionation, as ATG39 is specifically localized to the nuclear envelope . Increasing the protein load (50-100 μg per lane) while maintaining good electrophoretic separation using gradient gels (4-15%) improves detection of low abundance targets. Signal amplification systems such as biotin-streptavidin detection or tyramide signal amplification can increase sensitivity by 10-50 fold compared to standard detection methods . For immunoprecipitation, using larger starting material volumes (from 10^8 to 10^9 cells) combined with more concentrated antibody solutions (5-10 μg/ml) and extended incubation times (overnight at 4°C) maximizes target capture. In microscopy applications, signal-to-noise ratio can be improved by using quantum dots or newer generation fluorophores with higher quantum yields and reduced photobleaching. Background reduction techniques including longer blocking steps (2-3 hours) with 5% BSA supplemented with 0.1% casein further improve signal specificity. For cells with very low expression, nucleophagy induction via nitrogen starvation or rapamycin treatment (200 nM, 3-6 hours) upregulates ATG39 expression, making detection more feasible . Additionally, tyramide signal amplification microscopy protocols can amplify weak signals while preserving spatial resolution. For all applications, using highly purified antibodies (affinity-purified rather than crude serum) at optimized concentrations determined through careful titration experiments yields the best results with minimal background.

How can quantitative proteomics approaches be combined with ATG39 antibodies to map the nucleophagy interactome?

Combining quantitative proteomics with ATG39 antibodies offers powerful approaches for comprehensively mapping the nucleophagy interactome. Researchers can employ antibody-based proximity labeling techniques such as BioID or APEX2, where ATG39 is fused to a biotin ligase or peroxidase. After activation, proteins in close proximity to ATG39 become biotinylated and can be purified using streptavidin beads, followed by mass spectrometry identification . Stable isotope labeling with amino acids in cell culture (SILAC) coupled with ATG39 immunoprecipitation enables quantitative comparison between basal and induced nucleophagy states, revealing condition-specific interaction partners. For capturing transient interactions, researchers can utilize crosslinking immunoprecipitation-mass spectrometry (CLIP-MS), where cells are treated with chemical crosslinkers before ATG39 immunoprecipitation . Selective protein proximity analysis using split enzyme complementation tags (SPECS) with one fragment fused to ATG39 and a library of candidates fused to the complementary fragment can validate direct interactions in situ. Time-resolved proteomics, where samples are collected at multiple timepoints after nucleophagy induction, provides insights into the temporal dynamics of the ATG39 interactome during NDV formation. To distinguish between nuclear envelope and autophagosome components that interact with ATG39, researchers can perform comparative analysis of ATG39 interactomes in wild-type versus autophagy-deficient strains (e.g., atg1Δ or atg8Δ) . Combining these approaches with bioinformatic analysis of protein-protein interaction networks and functional categorization yields a comprehensive map of the nucleophagy interaction landscape.

What approaches can researchers use to study potential post-translational modifications of ATG39 using specific antibodies?

Studying post-translational modifications (PTMs) of ATG39 requires specialized antibody-based approaches tailored to each modification type. For phosphorylation analysis, researchers should use phospho-specific antibodies developed against predicted phosphorylation sites in ATG39, particularly focusing on residues in the N-terminal region that might regulate interactions with Atg8 and Atg11 . Immunoprecipitation with general ATG39 antibodies followed by western blotting with phospho-specific antibodies can detect phosphorylation under different conditions, such as comparing normal growth versus starvation or rapamycin treatment . For comprehensive PTM mapping, researchers can perform immunoprecipitation using ATG39 antibodies followed by mass spectrometry analysis optimized for PTM detection. This approach is particularly powerful when combined with SILAC or TMT labeling to quantitatively compare modification states between conditions. Ubiquitination can be studied by immunoprecipitating ATG39 under denaturing conditions to disrupt non-covalent interactions, followed by western blotting with anti-ubiquitin antibodies . For studying dynamic PTM changes, pulse-chase experiments using metabolic labeling combined with sequential immunoprecipitation at different timepoints after nucleophagy induction provide temporal resolution. Site-directed mutagenesis of potential modification sites, followed by immunoprecipitation and functional assays, can establish the biological significance of specific PTMs. The following table summarizes potential methods for studying different ATG39 modifications:

How might ATG39 antibodies contribute to understanding cross-talk between nucleophagy and other cellular stress responses?

ATG39 antibodies provide valuable tools for exploring the complex interplay between nucleophagy and various cellular stress response pathways. To investigate connections with the unfolded protein response (UPR), researchers can perform co-immunoprecipitation using ATG39 antibodies followed by detection of UPR components like Ire1 or Hac1, particularly under conditions that activate both pathways such as ER stress inducers combined with rapamycin . Chromatin immunoprecipitation sequencing (ChIP-seq) using antibodies against transcription factors involved in stress responses, combined with ATG39 expression analysis, can reveal transcriptional co-regulation networks linking different stress pathways. For studying spatial relationships between stress granules and sites of nucleophagy, multi-color immunofluorescence microscopy with ATG39 antibodies and markers for stress granules (e.g., Pab1) or P-bodies (e.g., Dcp2) reveals potential physical interactions between these structures . Proximity ligation assays using ATG39 antibodies paired with antibodies against components of other stress pathways provide in situ evidence of molecular proximity. Time-course studies examining ATG39 localization and abundance following various stresses (oxidative, heat shock, DNA damage) using immunofluorescence and western blotting reveal the temporal relationship between nucleophagy activation and other stress responses . For functional studies, genetic approaches where genes involved in other stress pathways are deleted or overexpressed, followed by analysis of ATG39 behavior using specific antibodies, can establish causal relationships. Quantitative proteomic analysis of samples immunoprecipitated with ATG39 antibodies from cells subjected to different stress conditions identifies stress-specific interaction partners, providing mechanistic insights into pathway crosstalk.